Tamoxifen-induced severe hypertriglyceridemia and pancreatitis

被引：47

作者：

Elisaf, MS ^{[1
]}

Nakou, K ^{[1
]}

Liamis, G ^{[1
]}

Pavlidis, NA ^{[1
]}

机构：

[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece

来源：

ANNALS OF ONCOLOGY | 2000年 / 11卷 / 08期

关键词：

hypertriglyceridemia; pancreatitis; tamoxifen;

D O I：

10.1023/A:1008309613082

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Tamoxifen exhibits favorable effects on the lipid and lipoprotein profile since it decreases the total and LDL cholesterol levels as well as the Lp(a) levels. Additionally, a small increase in serum triglycerides is commonly found after tamoxifen administration. However, severe hypertriglyceridemia which can sometimes be associated with life-threatening complications is occasionally noticed. Herein, we describe a patient who developed tamoxifen-induced severe hypertriglyceridemia and pancreatitis. An analysis of the underlying pathogenetic mechanisms as well as a review of the relevant literature is also provided.

引用

页码：1067 / 1069

页数：3

共 27 条

[1]

APPLEBAUMBOWDEN D, 1989, J LIPID RES, V30, P1895

[2] EFFECTS OF TAMOXIFEN TREATMENT ON PLASMA-LIPIDS AND LIPOPROTEIN LIPID-COMPOSITION [J].

BAGDADE, JD ;

WOLTER, J ;

SUBBAIAH, PV ;

RYAN, W .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :1132-1135

[3] ADJUVANT TAMOXIFEN IN PRIMARY BREAST-CANCER - INFLUENCE ON PLASMA-LIPIDS AND ANTITHROMBIN-III LEVELS [J].

BERTELLI, G ;

PRONZATO, P ;

AMOROSO, D ;

CUSIMANO, MP ;

CONTE, PF ;

MONTAGNA, G ;

BERTOLINI, S ;

ROSSO, R .

BREAST CANCER RESEARCH AND TREATMENT, 1988, 12 (03) :307-310

[4]

BRUN LD, 1986, CANCER, V57, P2123, DOI 10.1002/1097-0142(19860601)57:11<2123::AID-CNCR2820571106>3.0.CO

[5]

2-2

[6] TAMOXIFEN, SERUM-LIPOPROTEINS AND CARDIOVASCULAR RISK [J].

BRUNING, PF ;

BONFRER, JMG ;

HART, AAM ;

DEJONGBAKKER, M ;

LINDERS, D ;

VANLOON, J ;

NOOYEN, WJ .

BRITISH JOURNAL OF CANCER, 1988, 58 (04) :497-499

[7]

Colls B M, 1998, Clin Oncol (R Coll Radiol), V10, P270, DOI 10.1016/S0936-6555(98)80019-8

[8]

Elisaf M, 1996, ANTICANCER RES, V16, P2725

[9] PLASMA CHANGES IN BREAST-CANCER PATIENTS DURING ENDOCRINE THERAPY - LIPID MEASUREMENTS AND NUCLEAR-MAGNETIC-RESONANCE (NMR) SPECTROSCOPY [J].

ENGAN, T ;

KRANE, J ;

JOHANNESSEN, DC ;

LONNING, PE ;

KVINNSLAND, S .

BREAST CANCER RESEARCH AND TREATMENT, 1995, 36 (03) :287-297

[10]

GLUECK CJ, 1994, J LAB CLIN MED, V123, P59

← 1 2 3 →